cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Accuray Incorporated
22 own
37 watching
Current Price
$3.63
$0.05
(1.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
346.88M
52-Week High
52-Week High
3.86
52-Week Low
52-Week Low
1.7
Average Volume
Average Volume
0.33M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
43.857
iconMarket Capitalization346.88M
icon52-Week High3.86
icon52-Week Low1.7
iconAverage Volume0.33M
iconDividend Yield--
iconP/E Ratio43.857
What does the Accuray Incorporated do?
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. The company markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors and sales agents in Europe, Japan and other countries of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
Read More
How much money does Accuray Incorporated make?
News & Events about Accuray Incorporated.
PR Newswire
3 months ago
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men...
PR Newswire
4 months ago
European Radiosurgery Center Munich Invests in Second Accuray CyberKnife System to Support the Demand for High-Precision Radiosurgery Treatments European Radiosurgery Center Munich Invests in Second Accuray CyberKnife System to Support the Demand for High-Precision Radiosurgery Treatments PR...
PR Newswire
5 months ago
Automated Breast Ultrasound Systems Market was estimated at $1.5 Billion in 2021 and is growing at a CAGR of 14.4% from 2022 to 2032: Market Decipher Automated Breast Ultrasound Systems Market was estimated at $1.5 Billion in 2021 and is growing at a CAGR of 14.4% from 2022 to 2032...
Globe Newswire
5 months ago
LYON, France, December 6, 2022 -- EDAP TMS SA (NASDAQ: EDAP) (the Company), the global leader in robotic energy-based therapies, announced today that the Company has hired medical capital equipment finance industry veteran Ken Mobeck as Chief Financial Officer of EDAP Technomed Inc., the Companys U....
PR Newswire
6 months ago
Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022 Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022 PR Newswire SUNNYVALE, Calif., Nov. 28, 2022 SUNNYVALE, Calif., Nov. 28, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced...
Frequently Asked Questions
Frequently Asked Questions
What is Accuray Incorporated share price today?
plus_minus_icon
Can Indians buy Accuray Incorporated shares?
plus_minus_icon
How can I buy Accuray Incorporated shares from India?
plus_minus_icon
Can Fractional shares of Accuray Incorporated be purchased?
plus_minus_icon
What are the documents required to start investing in Accuray Incorporated stocks?
plus_minus_icon
What is today’s traded volume of Accuray Incorporated?
plus_minus_icon
What is today’s market capitalisation of Accuray Incorporated?
plus_minus_icon
What is the 52-Week High and Low Range of Accuray Incorporated?
plus_minus_icon
What percentage is Accuray Incorporated down from its 52-Week High?
plus_minus_icon
What percentage is Accuray Incorporated up from its 52-Week Low?
plus_minus_icon
Current Price
$3.63
$0.05
(1.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
MacroGenics, Inc.
MacroGenics, Inc.
$5.10
$-0.05 (-0.97 %)
MiMedx Group, Inc.
MiMedx Group, Inc.
$5.77
$0.09 (1.58 %)
ORTHOFIX MEDICAL INC
ORTHOFIX MEDICAL INC
$18.86
$-0.08 (-0.42 %)
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc.
$1.11
$0.02 (1.83 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
MacroGenics, Inc.
MacroGenics, Inc.
$5.10
$-0.05 (-0.97 %)
MiMedx Group, Inc.
MiMedx Group, Inc.
$5.77
$0.09 (1.58 %)
ORTHOFIX MEDICAL INC
ORTHOFIX MEDICAL INC
$18.86
$-0.08 (-0.42 %)
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc.
$1.11
$0.02 (1.83 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00